64 studies found for:
Raynaud
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 21 | Completed |
St. John's Wort in the Treatment of Raynaud's Phenomenon
|
||||
| 22 | Terminated |
Efficacy of ORM-12741 for Prevention of Raynaud's Phenomenon
|
||||
| 23 |
Completed
Has Results |
Efficacy Study of PDE-5 Inhibitor and Calcium Channel Inhibitor for the Treatment of Secondary Raynaud Phenomenon
|
||||
| 24 | Completed |
Trial of IC351 in Female Scleroderma Patients With Raynaud's and Sexual Dysfunction
|
||||
| 25 | Completed |
Safety and Efficacy of Pletal (Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud’s Phenomenon
|
||||
| 26 | Completed |
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Iloprost for Raynaud's Phenomenon Secondary to Systemic Sclerosis
|
||||
| 27 | Completed |
Safety and Efficacy of Pletal(Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud’s Phenomenon
|
||||
| 28 | Recruiting |
A Two-Part Study of BOTOX® Therapy for Ischemic Digits
|
||||
| 29 | Completed |
Raynaud's Treatment Study (RTS)
|
||||
| 30 | Recruiting |
Laser Speckle Contrast Imaging for Cutaneous Microvascular Dysfunction Detection in Systemic Sclerosis.
|
||||
| 31 | Unknown † |
Effect of Sildenafil on the Microcirculatory Blood Flow and Endothelial Progenitor Cells in Systemic Sclerosis
|
||||
| 32 |
Completed
Has Results |
Efficacy of Ambrisentan in Limited Scleroderma Patients in Improving Blood Flow to Hands or Feet
|
||||
| 33 | Completed |
MQX-503 Applied to the Hand Versus Nitroglycerin Ointment Applied to the Chest: A Pharmacokinetic Comparison
|
||||
| 34 | Recruiting |
Assessment of the Subcutaneous Reinjection of Human Autologous Adipose-derived Stromal Vascular Fraction (Celution® System) in the Hands of Patients Suffering From Systemic Sclerosis
|
||||
| 35 | Completed |
Phase II Study of Recombinant Relaxin for Progressive Systemic Sclerosis
|
||||
| 36 | Recruiting |
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
|
||||
| 37 | Completed |
Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine
|
||||
| 38 | Completed |
Sildenafil for Treatment of Digital Ulcers in Patients With Systemic Sclerosis
|
||||
| 39 | Recruiting |
Sildenafil Effect on Digital Ulcer Healing in sClerodErma SEDUCE STUDY
|
||||
| 40 | Recruiting |
Belimumab for the Treatment of Diffuse Cutaneous Systemic Sclerosis
|
† Indicates status has not been verified in more than two years

